Kazia Therapeutics Ltd.
13F holders, Q4 2024 (December 31)11holders +10
12new positions
1sold out
$1.77avg. 13F price*
At the end of Q4 2024, 11 institutions reported holding Kazia Therapeutics Ltd. in their 13F filings, up 10 from Q3 2024. 12 opened new positions and 1 sold out. The largest holders were MAI Capital Management ($246K), Barclays PLC ($212K) and UBS Group AG ($49K).
- Company
- Kazia Therapeutics Ltd.
- CUSIP
- 48669G204
- Latest filing quarter
- Q1 2025
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 12 | $569K |
| Exits | 1 | $7K |
All 13F filers, Q3 2024 → Q4 2024: 321,669 shares bought and 15,265 shares sold, net +306,404 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 11 holders
| MAI Capital Management | 0.00% | New | 139,208 | $246K |
| Barclays PLC | 0.00% | New | 120,000 | $212K |
| UBS Group AG | 0.00% | New | 27,547 | $49K |
| Morgan Stanley | 0.00% | New | 23,442 | $41K |
| JPMorgan Chase & Co. | 0.00% | New | 7,204 | $13K |
| Rhumbline Advisers | 0.00% | New | 2,778 | $5K |
| Citigroup Inc. | 0.00% | New | 720 | $1K |
| Simplex Trading, LLC | 0.00% | New | 710 | $1K |
| Osaic Holdings, Inc. | 0.00% | New | 50 | $88 |
| Allworth Financial LP | 0.00% | New | 8 | $11 |
| Wells Fargo & Company | 0.00% | New | 2 | $4 |
"% of holder's portfolio" is KAZIA THERAPEUTICS LTD's weight in each manager's 13F, not the share of Kazia Therapeutics Ltd. the manager owns.